Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Yant

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|July 31, 2013
Evaluation of the effect of cobicistat on the in vitro renal transport and cytotoxicity potential of tenofovirKirsten M Stray, Rujuta A Bam, Gabriel Birkus, et al.
Mbio|April 17, 2025
Impact of HIV-1 capsid polymorphisms on viral infectivity and susceptibility to lenacapavirDerek Hansen, Matthew R Hendricks, Silvia Chang, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear CellsRujuta A Bam, Derek Hansen, Alivelu Irrinki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2002
In vivo correction of murine tyrosinemia type I by DNA-mediated transpositionEugenio Montini, Patrice K Held, Meenakshi Noll, et al.
Plos One|September 17, 2013
Non-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cellsMini Balakrishnan, Stephen R Yant, Luong Tsai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2007
Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon deliveryHatem Zayed, Lily Xia, Anton Yerich, et al.
Blood|January 18, 2006
Host factors that impact the biodistribution and persistence of multipotent adult progenitor cellsJakub Tolar, Matthew J O'shaughnessy, Angela Panoskaltsis-Mortari, et al.
Science Translational Medicine|January 7, 2026
Lenacapavir treatment-emergent HIV-1 capsid resistance mutations are frequently associated with replication defectsNina Pennetzdorfer, Vidula Naik, Sally Demirdjian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2005
Real-time in vivo imaging of stem cells following transgenesis by transpositionJakub Tolar, Mark Osborn, Scott Bell, et al.
Antimicrobial Agents and Chemotherapy|September 21, 2016
Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance ProfileManuel Tsiang, Gregg S Jones, Joshua Goldsmith, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|July 31, 2013
Evaluation of the effect of cobicistat on the in vitro renal transport and cytotoxicity potential of tenofovirKirsten M Stray, Rujuta A Bam, Gabriel Birkus, et al.
Mbio|April 17, 2025
Impact of HIV-1 capsid polymorphisms on viral infectivity and susceptibility to lenacapavirDerek Hansen, Matthew R Hendricks, Silvia Chang, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear CellsRujuta A Bam, Derek Hansen, Alivelu Irrinki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2002
In vivo correction of murine tyrosinemia type I by DNA-mediated transpositionEugenio Montini, Patrice K Held, Meenakshi Noll, et al.
Plos One|September 17, 2013
Non-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cellsMini Balakrishnan, Stephen R Yant, Luong Tsai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2007
Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon deliveryHatem Zayed, Lily Xia, Anton Yerich, et al.
Blood|January 18, 2006
Host factors that impact the biodistribution and persistence of multipotent adult progenitor cellsJakub Tolar, Matthew J O'shaughnessy, Angela Panoskaltsis-Mortari, et al.
Science Translational Medicine|January 7, 2026
Lenacapavir treatment-emergent HIV-1 capsid resistance mutations are frequently associated with replication defectsNina Pennetzdorfer, Vidula Naik, Sally Demirdjian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2005
Real-time in vivo imaging of stem cells following transgenesis by transpositionJakub Tolar, Mark Osborn, Scott Bell, et al.
Antimicrobial Agents and Chemotherapy|September 21, 2016
Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance ProfileManuel Tsiang, Gregg S Jones, Joshua Goldsmith, et al.
Pageof 4